REMINDER: Our focusIR Investor Webinar takes place TONIGHT with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPhoenix Group Holdings Regulatory News (PHNX)

Share Price Information for Phoenix Group Holdings (PHNX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 505.00
Bid: 505.00
Ask: 506.00
Change: -3.50 (-0.69%)
Spread: 1.00 (0.198%)
Open: 507.00
High: 507.50
Low: 502.50
Prev. Close: 508.50
PHNX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Final Result of Tender Offer

5 Dec 2023 11:42

RNS Number : 7444V
Phoenix Group Holdings PLC
05 December 2023
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION TO ANY U.S. PERSON (as defined in regulation s under THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT")) ("U.S. PERSON") OR IN OR INTO THE UNITED STATES OF AMERICA, ITS TERRITORIES AND POSSESSIONS (THE "UNITED STATES") OR in or into ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS ANNOUNCEMENT.

5 December 2023

Phoenix Group Holdings plc announces Final Results and Pricing of Offers

Phoenix Group Holdings plc (the "Company") now announces the final results and pricing of its invitations made to the holders (the "Noteholders") of its outstanding £428,113,000 6.625 per cent. Subordinated Notes due 2025 (ISIN: XS1171593293) (the "Sterling Notes") and/or its U.S.$500,000,000 Fixed Rate Reset Tier 2 Notes due 2031 (ISIN: XS2182954797) (the "U.S.$ Notes" and, together with the Sterling Notes, the "Notes") as described in the tender offer memorandum dated 27 November 2023 (the "Tender Offer Memorandum") (each such invitation an "Offer" and together the "Offers").

Capitalised terms used but not otherwise defined in this announcement shall have the meanings given to them in the Tender Offer Memorandum.

The Expiration Deadline for the Offers was 16:00 (London time) on 4 December 2023. The pricing of the Offer for the Sterling Notes took place at or around 11:00 (London time) today.

The Company hereby announces that it will accept for purchase in accordance with the terms and subject to the conditions (including the satisfaction or waiver of the Financing Condition) set out in the Tender Offer Memorandum and at the relevant Purchase Price, validly tendered Notes for purchase pursuant to the Offers, in an aggregate principal amount of approximately £350,000,000 (equivalent). The Company further announces that the aggregate principal amount of each Series accepted for purchase (each a "Series Acceptance Amount") will be as set out in the table below.

Pricing of the Offer for the Sterling Notes is also set out in the table below.

 

Description

ISIN/Common Code

Benchmark Security Rate

Fixed Spread

Purchase Price

Purchase Yield

Series Acceptance Amount

Scaling Factor (Priority Tendered Notes)*

Scaling Factor (Non-Priority Tendered Notes)*

£428,113,000 6.625 per cent. Subordinated Notes due 2025

XS1171593293/117159329

4.565 per cent.

+115 basis points

101.539 per cent.

5.797 per cent. (annual)

£230,949,000

None applied

67.7999%

U.S.$500,000,000 Fixed Rate Reset Tier 2 Notes due 2031

XS2182954797/218295479

Not Applicable

Not Applicable

94.75 per cent.

Not Applicable

U.S.$150,000,000

None applied

43.7367%

* In line with the approach specified in the Tender Offer Memorandum, where Tender and Priority Acceptance Instructions related to a greater principal amount of Notes (on an aggregate basis taking into account tenders for such Noteholder of both the Sterling Notes and the U.S.$ Notes) than the principal amount of New Notes (converted in whole or in part into U.S.$ at the U.S.$ FX Rate and rounded down to the nearest U.S.$1,000, if applicable) it subscribed for and was allocated, the Company has, in its sole discretion, deemed the relevant Tender and Priority Acceptance Instruction or Tender and Priority Acceptance Instructions to be (A) Tender and Priority Acceptance Instruction(s) for only the principal amount of Notes in respect of which the relevant Noteholder has obtained Priority Acceptance and (B) Tender Only Instruction(s) for the additional Notes the relevant Noteholder wishes to tender for purchase in excess of such Priority Acceptance Amount, applying such approach to a Noteholder(s) Tender Instructions in a manner that is determined in the Company's sole discretion.

Subject to the satisfaction (or waiver) of the Financing Condition, payment of the relevant Purchase Price and the relevant Accrued Interest Payment in respect of the Notes accepted for purchase by the Company will occur on the Settlement Date for the Offers which is expected to be 7 December 2023.

Notes purchased by the Company pursuant to the Offers will be cancelled by the Company and will not be re-issued or re-sold. Notes which have not been validly submitted or validly submitted but not accepted for purchase pursuant to the Offers will remain outstanding, subject to their existing terms and conditions.

Any requests for information in relation to the Offers should be directed to the Dealer Managers or the Tender Agent whose contact details are: Banco Bilbao Vizcaya Argentaria, S.A. at 44th Floor, One Canada Square, London E14 5AA, United Kingdom, Attention: Liability Management, or by telephone at +44 207 397 6029 and +44 207 397 6061 or email liabilitymanagement@bbva.com; HSBC Bank plc at 8 Canada Square, London E14 5HQ, United Kingdom, Attention: Liability Management, DCM, or by telephone at +44 20 7992 6237 or email LM_EMEA@hsbc.com; J.P. Morgan Securities plc at 25 Bank Street, Canary Wharf, London E14 5JP, United Kingdom, Attention: EMEA Liability Management Group, or by telephone at +44 20 7134 2468 or email liability_management_EMEA@jpmorgan.com; Merrill Lynch International at 2 King Edward Street, London EC1A 1HQ, United Kingdom, Attention: Liability Management Group, or by telephone at +44 20 7996 5420 or email DG.LM-EMEA@bofa.com; NatWest Markets Plc at 250 Bishopsgate, London EC2M 4AA, United Kingdom, Attention: Liability Management, or by telephone at +44 20 7678 5222 or email NWMliabilitymanagement@natwestmarkets.com; and Kroll Issuer Services Limited at The Shard, 32 London Bridge Street, London SE1 9SG, United Kingdom, Attention: Jacek Kusion, or by telephone at +44 20 7704 0880 or email phoenix@is.kroll.com.

REGULATORY INFORMATION AND DISCLAIMER

 

This announcement contains information that qualified or may have qualified as inside information within the meaning of Article 7(1) of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 (as amended, the "EUWA").

The person responsible for arranging release of this announcement on behalf of the Company is Kulbinder Dosanjh, Group Company Secretary. The Legal Entity Identifier of the Offeror is: 2138001P49OLAEU33T68.

This announcement must be read in conjunction with the Tender Offer Memorandum. This announcement and the Tender Offer Memorandum contain important information which should be read carefully before any decision is made with respect to the Offers. If any Noteholder is in any doubt as to the contents of this announcement, the Tender Offer Memorandum or the action it should take, it is recommended to seek its own financial, legal, regulatory and any other advice, including in respect of any financial, accounting, regulatory and tax consequences, immediately from its broker, bank manager, solicitor, accountant or other independent financial, tax or legal adviser.

The distribution of this announcement and the Tender Offer Memorandum in certain jurisdictions may be restricted by law. Persons into whose possession this announcement and/or the Tender Offer Memorandum comes are required by each of the Company, the Dealer Managers and the Tender Agent to inform themselves about, and to observe, any such restrictions.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RTEDZMGZMKGGFZM
Date   Source Headline
30th Apr 202012:30 pmRNSTotal Voting Rights
27th Apr 20201:00 pmRNSPublication of Final Terms
22nd Apr 20205:15 pmRNSHolding(s) in Company
21st Apr 20204:31 pmRNSPublication of Supplemental Prospectus
21st Apr 20203:30 pmRNSDirector/PDMR Shareholding
17th Apr 202012:00 pmRNS2020 AGM - Revised Arrangements
14th Apr 20205:15 pmRNSHolding(s) in Company
9th Apr 20204:15 pmRNSHolding(s) in Company
9th Apr 202011:00 amRNSDirector/PDMR Shareholding
31st Mar 20202:00 pmRNSTotal Voting Rights
27th Mar 20209:00 amRNSDirector/PDMR Shareholding
27th Mar 20209:00 amRNSDirector/PDMR Shareholding
23rd Mar 20204:25 pmRNSNotice of AGM
19th Mar 20205:30 pmRNSDirector/PDMR Shareholding
19th Mar 20205:30 pmRNSDirector/PDMR Shareholding
19th Mar 20205:30 pmRNSDirector/PDMR Shareholding
17th Mar 20203:00 pmRNSDirector/PDMR Shareholding
16th Mar 20205:15 pmRNSDirector/PDMR Shareholding
16th Mar 20203:30 pmRNSDirector/PDMR Shareholding
16th Mar 20203:30 pmRNSDirector/PDMR Shareholding
12th Mar 20203:45 pmRNSDirector/PDMR Shareholding
12th Mar 20203:45 pmRNSDirector/PDMR Shareholding
11th Mar 202010:30 amRNSDirector/PDMR Shareholding
10th Mar 20204:45 pmRNSHolding(s) in Company
10th Mar 20203:15 pmRNSPublication of Suppl.Prospcts
9th Mar 202012:45 pmRNSDirector/PDMR Shareholding
9th Mar 20207:00 amRNSDirectorate Change
9th Mar 20207:00 amRNS2019 Annual Financial Results
3rd Mar 20205:30 pmRNSHolding(s) in Company
28th Feb 20202:30 pmRNSTotal Voting Rights
13th Feb 202010:55 amRNSResults of General Meeting
11th Feb 20207:00 amRNSBoard Changes
10th Feb 202011:00 amRNSDirector/PDMR Shareholding
31st Jan 20202:00 pmRNSTotal Voting Rights
27th Jan 20203:45 pmRNSPublication of Offering Memorandum
27th Jan 202010:00 amRNSHolding(s) in Company
24th Jan 20204:00 pmRNSHolding(s) in Company
17th Jan 20204:00 pmRNSPublication of Suppl.Prospcts
17th Jan 20203:30 pmRNSPublication of a Prospectus
8th Jan 20202:30 pmRNSDirector/PDMR Shareholding
31st Dec 20199:00 amRNSTotal Voting Rights
19th Dec 20192:00 pmRNSBlock listing Return
9th Dec 20194:00 pmRNSDirector/PDMR Shareholding
6th Dec 20197:00 amRNSProposed acquisition of ReAssure Group plc
29th Nov 20192:00 pmRNSTotal Voting Rights
28th Nov 20197:00 amRNSPhoenix Group Holdings plc - Trading Update
8th Nov 20197:00 amRNSPhoenix Group Holdings plc - Board Changes
6th Nov 20193:00 pmRNSDirector/PDMR Shareholding
31st Oct 201910:15 amRNSTotal Voting Rights
9th Oct 201912:30 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.